Organisatie
Hiv/soa-kliniek
Huidige onderzoekers
1 - 10 of 20 results
- Maureen Aerts (Lid)
- Ludwig Apers (Lid)
- Vincent Barvaux (Lid)
- Séverine Caluwaerts (Lid)
- Emmanuelle Cleve (Lid)
- Eva Hemelaer (Lid)
- Corinne Herrijgers (Lid)
- Veerle Huyst (Lid)
- Ilse Kint (Lid)
- Cora Lamonte (Lid)
Projecten
1 - 9 of 9
- Contemporary challenges in Human Immunodeficiency Virus Pre-Exposure-Prophylaxis care in BelgiumVanaf15 nov 2022 → Heden
- De opkomst van onbehandelbare soa's voorkomen via radicale preventieVanaf1 jan 2021 → Heden
- Development and evaluation of a computerized intervention for chemsex supportVanaf19 nov 2020 → 31 dec 2021
- Chemified: pilot testing of a mobile application for chemsexcare and supportVanaf20 okt 2020 → 20 okt 2021
- Optimaliseren van PrEP om Impact te MaximaliserenVanaf1 jan 2019 → 31 dec 2023
- Evaluating mHealth technology in HIV to improve Empowerment and healthcare utilisation: Research and innovation to Generate Evidence for personalised careVanaf1 mei 2015 → 30 sep 2020
- Analytical treatment interruption in HIV positive patients with low viral reservoir to evaluate the potential of a functional cureVanaf1 nov 2014 → 31 okt 2018
- Hepatitis C treatment for HIV patients in resource-poor countries: is a public health approach possibleVanaf1 jul 2014 → 31 dec 2019
- Euro HIV EDAT - Operational knowledge to improve HIV early diagnosis and treatment among vulnerable groups in EuropeVanaf1 apr 2014 → 30 sep 2017
Publicaties
21 - 30 van 296
- Clinical characteristics and outcomes of COVID-19 in people living with HIV in Belgium: a multicenter, retrospective cohort(2021)
Auteurs: Rakan Nasreddine, E Florence, Michel MOUTSCHEN, Jean Cyr Yombi, Jean-Christophe Goffard, Inge Derdelinckx, Patrick Lacor, Linos Vandekerckhove, Peter Messiaen, Stefaan Vandecasteele, et al.
Pagina's: 2971-2978 - Treatment of acute hepatitis C genotypes 1 and 4 with 8 weeks of grazoprevir plus elbasvir (DAHHS2): an open-label, multicentre, single-arm, phase 3b trial(2019)
Auteurs: Anne Boerekamps, Anja De Weggheleire, Guido E van den Berk, Fanny N Lauw, Mark A A Claassen, Dirk Posthouwer, Wouter F Bierman, Sebastiaan J Hullegie, Stephanie Popping, David A C M van de Vijver, et al.
Pagina's: 269-277 - Self-reported signs of lipodystrophy by persons living with HIV infection(2002)
Auteurs: CHRISTA DREEZEN, W Schrooten, I de Mey, FD Goebel, N. Dedes, E Florence, RL Colebunders, Group Eurosupport Study
Pagina's: 393-398 - Dental precautions for travelers [letter](1998)
Auteurs: E Florence, A Van Gompel, R Colebunders
Pagina's: 159 - Equal IgG antibody response to pneumococcal vaccination in all stages of human immunodeficiency virus disease(1995)
Auteurs: M Vandenbruaene, R Colebunders, F Mascart-Lemone, Y Haerden, D Van Hove, M Peeters, J Goeman, P Van Royen, D. Avonts
Pagina's: 551-553 - Multiple tuberculous brain abscesses in an HIV-infected patient successfully treated with HAART and antituberculous treatment(2003)
Auteurs: E Bottieau, A Noë, E Florence, R Colebunders
Pagina's: 118-120 - CD4 results with a bias larger than hundred cells per microliter can have a significant impact on the clinical decision during treatment initiation of HIV patients(2017)
Auteurs: Géraldine Daneau, Jozefien Buyze, Djibril Wade, Papa Alassane Diaw, Tandakha Ndeye Dieye, S. Thai, E Florence, Lutgarde Lynen, L Kestens
Pagina's: 476-484 - What is the appropriate therapy for asymptomatic gonorrhoea in men who have sex with men?(2016)
Auteurs: C. Kenyon, Kara OSBAK, M Vandenbruaene
Pagina's: 812-813 - Risk factors for HCV acquisition among HIV-positive MSM in Belgium(2015)
Auteurs: Ludwig Apers, W Vanden Berghe, Stéphane De Wit, Kabamba Kabeya, Steven Callens, Jozefien Buyze, C. Kenyon, E Florence, Anne Buvé
Pagina's: 585-593 - The use of erection enhancing medication and party drugs among men living with HIV in Europe(2013)
Auteurs: I. De Ryck, D. Van Laeken, C Nöstlinger, T Platteau, R. Colebunders
Pagina's: 1062-1066